Product Description: VK-0214 is an agonist for thyroid beta receptor (TRβ), which ameliorates the X-linked adrenoleukodystrophy (X-ALD), through activation of ABCD2 expression and reduction of very long chain fatty acids (VLCFA) accumulation[1].
Formula: C23H25O5P
References: [1]McGowan E, et al., Integrative Rare Disease Biomedical Profile based Network Supporting Drug Repurposing, a case study of Glioblastoma. Res Sq [Preprint]. 2023 Apr 18:rs.3.rs-2809689.
CAS Number: 852949-30-5
Molecular Weight: 412.42
Research Area: Neurological Disease
Target: Thyroid Hormone Receptor